282 related articles for article (PubMed ID: 38106403)
1. Advances in tumor immunomodulation based on nanodrug delivery systems.
Wang B; Zhang Y; Yin X
Front Immunol; 2023; 14():1297493. PubMed ID: 38106403
[TBL] [Abstract][Full Text] [Related]
2. Coadministration of iRGD peptide with ROS-sensitive nanoparticles co-delivering siFGL1 and siPD-L1 enhanced tumor immunotherapy.
Wan WJ; Huang G; Wang Y; Tang Y; Li H; Jia CH; Liu Y; You BG; Zhang XN
Acta Biomater; 2021 Dec; 136():473-484. PubMed ID: 34571271
[TBL] [Abstract][Full Text] [Related]
3. Dual pH-sensitive nanodrug blocks PD-1 immune checkpoint and uses T cells to deliver NF-κB inhibitor for antitumor immunotherapy.
Xiao Z; Su Z; Han S; Huang J; Lin L; Shuai X
Sci Adv; 2020 Feb; 6(6):eaay7785. PubMed ID: 32076650
[TBL] [Abstract][Full Text] [Related]
4. T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma.
Wang X; Zhang Q; Zhou J; Xiao Z; Liu J; Deng S; Hong X; Huang W; Cai M; Guo Y; Huang J; Wang Y; Lin L; Zhu K
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36813307
[TBL] [Abstract][Full Text] [Related]
5. A carrier-free photodynamic nanodrug to enable regulation of dendritic cells for boosting cancer immunotherapy.
Qin X; Zhang M; Zhao Z; Du Q; Li Q; Jiang Y; Xue F; Luan Y
Acta Biomater; 2022 Jul; 147():366-376. PubMed ID: 35588995
[TBL] [Abstract][Full Text] [Related]
6. Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles.
Gong C; Yu X; Zhang W; Han L; Wang R; Wang Y; Gao S; Yuan Y
J Nanobiotechnology; 2021 Feb; 19(1):58. PubMed ID: 33632231
[TBL] [Abstract][Full Text] [Related]
7. Reducing PD-L1 expression with a self-assembled nanodrug: an alternative to PD-L1 antibody for enhanced chemo-immunotherapy.
Cai S; Chen Z; Wang Y; Wang M; Wu J; Tong Y; Chen L; Lu C; Yang H
Theranostics; 2021; 11(4):1970-1981. PubMed ID: 33408792
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticle-based drug delivery systems to enhance cancer immunotherapy in solid tumors.
Zhang J; Wang S; Zhang D; He X; Wang X; Han H; Qin Y
Front Immunol; 2023; 14():1230893. PubMed ID: 37600822
[TBL] [Abstract][Full Text] [Related]
9. Lymphatic immunomodulation using engineered drug delivery systems for cancer immunotherapy.
Manspeaker MP; Thomas SN
Adv Drug Deliv Rev; 2020; 160():19-35. PubMed ID: 33058931
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional nanodrug performs sonodynamic therapy and inhibits TGF-β to boost immune response against colorectal cancer and liver metastasis.
Huang S; Ding D; Lan T; He G; Ren J; Liang R; Zhong H; Chen G; Lu X; Shuai X; Wei B
Acta Biomater; 2023 Jul; 164():538-552. PubMed ID: 37037269
[TBL] [Abstract][Full Text] [Related]
11. Charge-switchable nanoparticles enhance Cancer immunotherapy based on mitochondrial dynamic regulation and immunogenic cell death induction.
Zhao M; Li J; Liu J; Xu M; Ji H; Wu S; Chen D; Hu H
J Control Release; 2021 Jul; 335():320-332. PubMed ID: 34062192
[TBL] [Abstract][Full Text] [Related]
12. PEG-Sheddable Nanodrug Remodels Tumor Microenvironment to Promote Effector T Cell Infiltration and Revise Their Exhaustion for Breast Cancer Immunotherapy.
Huang T; Zhang Q; Yi J; Wang R; Zhang Z; Luo P; Zeng R; Wang Y; Tu M
Small; 2023 Sep; 19(38):e2301749. PubMed ID: 37211704
[TBL] [Abstract][Full Text] [Related]
13. TRAIL-modified, doxorubicin-embedded periodic mesoporous organosilica nanoparticles for targeted drug delivery and efficient antitumor immunotherapy.
Feng X; Li F; Zhang L; Liu W; Wang X; Zhu R; Qiao ZA; Yu B; Yu X
Acta Biomater; 2022 Apr; 143():392-405. PubMed ID: 35259519
[TBL] [Abstract][Full Text] [Related]
14. A review of matrix metalloproteinase-2-sensitive nanoparticles as a novel drug delivery for tumor therapy.
Zong L; Xu H; Zhang H; Tu Z; Zhang X; Wang S; Li M; Feng Y; Wang B; Li L; Xie X; He Z; Pu X
Int J Biol Macromol; 2024 Mar; 262(Pt 2):130043. PubMed ID: 38340921
[TBL] [Abstract][Full Text] [Related]
15. Tumor acidity-activatable macromolecule autophagy inhibitor and immune checkpoint blockade for robust treatment of prostate cancer.
Wang Y; Lei H; Yan B; Zhang S; Xu B; Lin M; Shuai X; Huang J; Pang J
Acta Biomater; 2023 Sep; 168():593-605. PubMed ID: 37474083
[TBL] [Abstract][Full Text] [Related]
16. Nanoengineered Immune Niches for Reprogramming the Immunosuppressive Tumor Microenvironment and Enhancing Cancer Immunotherapy.
Phuengkham H; Ren L; Shin IW; Lim YT
Adv Mater; 2019 Aug; 31(34):e1803322. PubMed ID: 30773696
[TBL] [Abstract][Full Text] [Related]
17. Hollow Cu2MoS4 nanoparticles loaded with immune checkpoint inhibitors reshape the tumor microenvironment to enhance immunotherapy for pancreatic cancer.
Yao Z; Qi C; Zhang F; Yao H; Wang C; Cao X; Zhao C; Wang Z; Qi M; Yao C; Wang X; Xia H
Acta Biomater; 2024 Jan; 173():365-377. PubMed ID: 37890815
[TBL] [Abstract][Full Text] [Related]
18. Harnessing biomaterial architecture to drive anticancer innate immunity.
Davis MA; Cho E; Teplensky MH
J Mater Chem B; 2023 Nov; 11(46):10982-11005. PubMed ID: 37955201
[TBL] [Abstract][Full Text] [Related]
19. Nano Ultrasound Contrast Agent for Synergistic Chemo-photothermal Therapy and Enhanced Immunotherapy Against Liver Cancer and Metastasis.
Qiu Y; Wu Z; Chen Y; Liao J; Zhang Q; Wang Q; Duan Y; Gong K; Chen S; Wang L; Fan P; Duan Y; Wang W; Dong Y
Adv Sci (Weinh); 2023 Jul; 10(21):e2300878. PubMed ID: 37162268
[TBL] [Abstract][Full Text] [Related]
20. Synchronous targeted delivery of TGF-β siRNA to stromal and tumor cells elicits robust antitumor immunity against triple-negative breast cancer by comprehensively remodeling the tumor microenvironment.
Yang M; Qin C; Tao L; Cheng G; Li J; Lv F; Yang N; Xing Z; Chu X; Han X; Huo M; Yin L
Biomaterials; 2023 Oct; 301():122253. PubMed ID: 37536040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
